1. Home
  2. CGEN vs LVRO Comparison

CGEN vs LVRO Comparison

Compare CGEN & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • LVRO
  • Stock Information
  • Founded
  • CGEN 1993
  • LVRO 2017
  • Country
  • CGEN Israel
  • LVRO Brazil
  • Employees
  • CGEN 74
  • LVRO N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • LVRO Blank Checks
  • Sector
  • CGEN Health Care
  • LVRO Finance
  • Exchange
  • CGEN Nasdaq
  • LVRO Nasdaq
  • Market Cap
  • CGEN 125.3M
  • LVRO 149.0M
  • IPO Year
  • CGEN 2000
  • LVRO N/A
  • Fundamental
  • Price
  • CGEN $1.38
  • LVRO $1.37
  • Analyst Decision
  • CGEN
  • LVRO Sell
  • Analyst Count
  • CGEN 0
  • LVRO 3
  • Target Price
  • CGEN N/A
  • LVRO $1.88
  • AVG Volume (30 Days)
  • CGEN 238.3K
  • LVRO 14.7K
  • Earning Date
  • CGEN 11-11-2025
  • LVRO 10-30-2025
  • Dividend Yield
  • CGEN N/A
  • LVRO N/A
  • EPS Growth
  • CGEN N/A
  • LVRO N/A
  • EPS
  • CGEN N/A
  • LVRO N/A
  • Revenue
  • CGEN $22,144,000.00
  • LVRO $1,667,345,189.00
  • Revenue This Year
  • CGEN N/A
  • LVRO N/A
  • Revenue Next Year
  • CGEN $159.40
  • LVRO $11.45
  • P/E Ratio
  • CGEN N/A
  • LVRO N/A
  • Revenue Growth
  • CGEN N/A
  • LVRO N/A
  • 52 Week Low
  • CGEN $1.13
  • LVRO $1.25
  • 52 Week High
  • CGEN $2.66
  • LVRO $5.60
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 41.92
  • LVRO 37.43
  • Support Level
  • CGEN $1.39
  • LVRO $1.25
  • Resistance Level
  • CGEN $1.47
  • LVRO $1.43
  • Average True Range (ATR)
  • CGEN 0.06
  • LVRO 0.11
  • MACD
  • CGEN -0.00
  • LVRO -0.00
  • Stochastic Oscillator
  • CGEN 33.33
  • LVRO 22.22

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

Share on Social Networks: